Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.89593044 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.89593044 |
3 | negative regulation of cell killing (GO:0031342) | 4.62856642 |
4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.62856642 |
5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.52861676 |
6 | ribosomal small subunit assembly (GO:0000028) | 4.44462258 |
7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.18483221 |
8 | modulation by symbiont of host defense response (GO:0052031) | 4.18483221 |
9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.18483221 |
10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.18483221 |
11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.18483221 |
12 | modulation by symbiont of host immune response (GO:0052553) | 4.18483221 |
13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.97756937 |
14 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.92988080 |
15 | detection of other organism (GO:0098543) | 3.89700409 |
16 | detection of bacterium (GO:0016045) | 3.86781301 |
17 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.77575531 |
18 | neutrophil activation involved in immune response (GO:0002283) | 3.69219198 |
19 | response to interferon-beta (GO:0035456) | 3.48103850 |
20 | regulation of mast cell degranulation (GO:0043304) | 3.37497891 |
21 | immunoglobulin mediated immune response (GO:0016064) | 3.29403708 |
22 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.28753988 |
23 | viral transcription (GO:0019083) | 3.24878854 |
24 | macrophage activation involved in immune response (GO:0002281) | 3.14587933 |
25 | translational termination (GO:0006415) | 3.14526965 |
26 | detection of external biotic stimulus (GO:0098581) | 3.14296263 |
27 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.12808224 |
28 | regulation of leukocyte degranulation (GO:0043300) | 3.10010137 |
29 | response to interferon-alpha (GO:0035455) | 3.08018615 |
30 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.07878726 |
31 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.06993453 |
32 | B cell mediated immunity (GO:0019724) | 3.04832782 |
33 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.04671902 |
34 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.01758094 |
35 | cellular response to type I interferon (GO:0071357) | 3.01249562 |
36 | type I interferon signaling pathway (GO:0060337) | 3.01249562 |
37 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.99944676 |
38 | response to host (GO:0075136) | 2.99944676 |
39 | response to host defenses (GO:0052200) | 2.99944676 |
40 | response to type I interferon (GO:0034340) | 2.99852870 |
41 | response to peptidoglycan (GO:0032494) | 2.98885470 |
42 | response to host immune response (GO:0052572) | 2.97053245 |
43 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.97053245 |
44 | cellular extravasation (GO:0045123) | 2.96631504 |
45 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.95170295 |
46 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.95152527 |
47 | actin nucleation (GO:0045010) | 2.94449564 |
48 | myeloid dendritic cell activation (GO:0001773) | 2.93487260 |
49 | negative regulation of interleukin-12 production (GO:0032695) | 2.92980598 |
50 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.92727959 |
51 | cellular response to interferon-beta (GO:0035458) | 2.91127689 |
52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.90578951 |
53 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.89092155 |
54 | T cell apoptotic process (GO:0070231) | 2.87468472 |
55 | cellular response to zinc ion (GO:0071294) | 2.87292263 |
56 | negative regulation of phagocytosis (GO:0050765) | 2.87016189 |
57 | regulation of gamma-delta T cell activation (GO:0046643) | 2.86872607 |
58 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.86553985 |
59 | protein targeting to ER (GO:0045047) | 2.85064764 |
60 | myeloid cell activation involved in immune response (GO:0002275) | 2.84258736 |
61 | cotranslational protein targeting to membrane (GO:0006613) | 2.83427718 |
62 | NIK/NF-kappaB signaling (GO:0038061) | 2.83298507 |
63 | response to protozoan (GO:0001562) | 2.83030415 |
64 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.81634722 |
65 | leukocyte degranulation (GO:0043299) | 2.81256686 |
66 | positive regulation of interferon-alpha production (GO:0032727) | 2.76060743 |
67 | translational elongation (GO:0006414) | 2.75969533 |
68 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.75934927 |
69 | myeloid dendritic cell differentiation (GO:0043011) | 2.74735176 |
70 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.74624730 |
71 | defense response to protozoan (GO:0042832) | 2.74356537 |
72 | positive regulation of B cell differentiation (GO:0045579) | 2.72707781 |
73 | positive regulation of mast cell activation (GO:0033005) | 2.71990501 |
74 | regulation of platelet aggregation (GO:0090330) | 2.71472355 |
75 | detection of biotic stimulus (GO:0009595) | 2.70719776 |
76 | response to muramyl dipeptide (GO:0032495) | 2.69375914 |
77 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.68408084 |
78 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.68112036 |
79 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.67637520 |
80 | germinal center formation (GO:0002467) | 2.67577755 |
81 | positive regulation of macrophage differentiation (GO:0045651) | 2.67008491 |
82 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.66883435 |
83 | protein localization to endoplasmic reticulum (GO:0070972) | 2.66505736 |
84 | pentose-phosphate shunt (GO:0006098) | 2.66153423 |
85 | neutrophil activation (GO:0042119) | 2.65583291 |
86 | maturation of SSU-rRNA (GO:0030490) | 2.64707092 |
87 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.64452797 |
88 | negative regulation of stress fiber assembly (GO:0051497) | 2.64267056 |
89 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.63667644 |
90 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.62980970 |
91 | detection of molecule of bacterial origin (GO:0032490) | 2.62673197 |
92 | regulation of protein heterodimerization activity (GO:0043497) | 2.62080451 |
93 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.61693873 |
94 | B cell receptor signaling pathway (GO:0050853) | 2.61281983 |
95 | platelet aggregation (GO:0070527) | 2.60828785 |
96 | ribosomal small subunit biogenesis (GO:0042274) | 2.59979331 |
97 | response to interleukin-15 (GO:0070672) | 2.59625250 |
98 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.59378297 |
99 | regulation of interferon-alpha production (GO:0032647) | 2.59353605 |
100 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.59138961 |
101 | granulocyte activation (GO:0036230) | 2.57983324 |
102 | negative regulation of viral genome replication (GO:0045071) | 2.57552978 |
103 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.57326361 |
104 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.56830977 |
105 | natural killer cell mediated immunity (GO:0002228) | 2.56830977 |
106 | hepatocyte apoptotic process (GO:0097284) | 2.55378412 |
107 | viral life cycle (GO:0019058) | 2.54995453 |
108 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.54790570 |
109 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.54474685 |
110 | tolerance induction (GO:0002507) | 2.54032556 |
111 | T-helper 1 type immune response (GO:0042088) | 2.53965508 |
112 | regulation of superoxide anion generation (GO:0032928) | 2.53778617 |
113 | membrane raft organization (GO:0031579) | 2.53286244 |
114 | positive regulation of antigen processing and presentation (GO:0002579) | 2.51423507 |
115 | DNA deamination (GO:0045006) | 2.51277777 |
116 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.51122883 |
117 | regulation of mast cell activation (GO:0033003) | 2.50876324 |
118 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.50290226 |
119 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.50290226 |
120 | regulation of RIG-I signaling pathway (GO:0039535) | 2.49968180 |
121 | COPI coating of Golgi vesicle (GO:0048205) | 2.49895228 |
122 | Golgi transport vesicle coating (GO:0048200) | 2.49895228 |
123 | lymphocyte apoptotic process (GO:0070227) | 2.49412910 |
124 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.48907774 |
125 | respiratory burst (GO:0045730) | 2.48665858 |
126 | protein localization to endosome (GO:0036010) | 2.47536934 |
127 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.47461563 |
128 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.47242686 |
129 | dendritic cell differentiation (GO:0097028) | 2.46287293 |
130 | DNA strand elongation (GO:0022616) | 2.46022102 |
131 | regulation of necroptotic process (GO:0060544) | 2.45077406 |
132 | negative regulation of innate immune response (GO:0045824) | 2.44909198 |
133 | barbed-end actin filament capping (GO:0051016) | 2.44628366 |
134 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.44584451 |
135 | angiogenesis involved in wound healing (GO:0060055) | 2.44037610 |
136 | endosome to pigment granule transport (GO:0043485) | 2.43936844 |
137 | endosome to melanosome transport (GO:0035646) | 2.43936844 |
138 | regulation of defense response to virus by virus (GO:0050690) | 2.42725566 |
139 | regulation of B cell differentiation (GO:0045577) | 2.42519540 |
140 | translational initiation (GO:0006413) | 2.42375601 |
141 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.42144957 |
142 | regulation of regulated secretory pathway (GO:1903305) | 2.41288640 |
143 | lipoxygenase pathway (GO:0019372) | 2.39871476 |
144 | negative regulation of T cell mediated immunity (GO:0002710) | 2.38490604 |
145 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.38215307 |
146 | positive regulation of isotype switching (GO:0045830) | 2.38040568 |
147 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.36960123 |
148 | regulation of natural killer cell differentiation (GO:0032823) | 2.36938287 |
149 | telomere maintenance via recombination (GO:0000722) | 2.36062669 |
150 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.35947648 |
151 | leukocyte mediated cytotoxicity (GO:0001909) | 2.35136162 |
152 | cellular protein complex disassembly (GO:0043624) | 2.34852206 |
153 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.33897300 |
154 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.33320817 |
155 | formation of translation preinitiation complex (GO:0001731) | 2.32628351 |
156 | sequestering of actin monomers (GO:0042989) | 2.31812900 |
157 | definitive hemopoiesis (GO:0060216) | 2.31606841 |
158 | leukocyte aggregation (GO:0070486) | 2.31532459 |
159 | regulation of antigen processing and presentation (GO:0002577) | 2.31437586 |
160 | pinocytosis (GO:0006907) | 2.30011972 |
161 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.26080767 |
162 | regulation of necrotic cell death (GO:0010939) | 2.25561389 |
163 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.24613226 |
164 | natural killer cell differentiation (GO:0001779) | 2.23406875 |
165 | positive regulation of lamellipodium assembly (GO:0010592) | 2.22959630 |
166 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.22724243 |
167 | positive regulation of interleukin-12 production (GO:0032735) | 2.21163214 |
168 | natural killer cell activation (GO:0030101) | 2.20738035 |
169 | regulation of hypersensitivity (GO:0002883) | 2.20278732 |
170 | leukocyte apoptotic process (GO:0071887) | 2.19177423 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.16583034 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.02671403 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.29573217 |
4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.25781595 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.92748062 |
6 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.91429532 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.72735665 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.72074648 |
9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.57916679 |
10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.43201241 |
11 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.40868755 |
12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.39170771 |
13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.31062891 |
14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.30403858 |
15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.29731559 |
16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.25828633 |
17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.21170069 |
18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10211289 |
19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.08634369 |
20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06829280 |
21 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04250491 |
22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02770584 |
23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.99636289 |
24 | MYC_22102868_ChIP-Seq_BL_Human | 1.96609121 |
25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.96057020 |
26 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94891946 |
27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93323718 |
28 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92757138 |
29 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91941971 |
30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.89275157 |
31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.86189800 |
32 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.85463906 |
33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.77516008 |
34 | * MYB_26560356_Chip-Seq_TH2_Human | 1.75818007 |
35 | * MAF_26560356_Chip-Seq_TH1_Human | 1.73689059 |
36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.73309919 |
37 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.70217208 |
38 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67099705 |
39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66497125 |
40 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.65551786 |
41 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64731013 |
42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.62682084 |
43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62151654 |
44 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61618284 |
45 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.61435601 |
46 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.57799721 |
47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56384873 |
48 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56117257 |
49 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.54265691 |
50 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.53639328 |
51 | * MYB_26560356_Chip-Seq_TH1_Human | 1.51518744 |
52 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.50124151 |
53 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.48183186 |
54 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.43208264 |
55 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.42982498 |
56 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.42195086 |
57 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.40439632 |
58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39025576 |
59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.38595408 |
60 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37972046 |
61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37967473 |
62 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37382900 |
63 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.36830347 |
64 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.35809043 |
65 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35513626 |
66 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34980519 |
67 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.34207304 |
68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31430373 |
69 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29889067 |
70 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.29621697 |
71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28978076 |
72 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.27796407 |
73 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.27664811 |
74 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27362348 |
75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27315035 |
76 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.25924698 |
77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25420827 |
78 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.25082760 |
79 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24422267 |
80 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.23619554 |
81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22571380 |
82 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.22042467 |
83 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.21629172 |
84 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19681001 |
85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18603984 |
86 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.17931272 |
87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17500485 |
88 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16975639 |
89 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16649878 |
90 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16622474 |
91 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16172920 |
92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15866951 |
93 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15861070 |
94 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15746122 |
95 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.15107320 |
96 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.14192288 |
97 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14044089 |
98 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.13057346 |
99 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13042483 |
100 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12680739 |
101 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.11454869 |
102 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10057087 |
103 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09913357 |
104 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09744800 |
105 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09531449 |
106 | * MAF_26560356_Chip-Seq_TH2_Human | 1.08882168 |
107 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08363405 |
108 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.08023215 |
109 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.07373912 |
110 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06984370 |
111 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06751564 |
112 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.06557745 |
113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05212021 |
114 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.05102413 |
115 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05036159 |
116 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.04763657 |
117 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.03757399 |
118 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03371719 |
119 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.03177717 |
120 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.03123361 |
121 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02897201 |
122 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02659386 |
123 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01955295 |
124 | P68_20966046_ChIP-Seq_HELA_Human | 1.01442929 |
125 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.00608853 |
126 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.00562882 |
127 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00435740 |
128 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99960120 |
129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99223626 |
130 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98605707 |
131 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98565138 |
132 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.98041437 |
133 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.98006733 |
134 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97517800 |
135 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97481680 |
136 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96687346 |
137 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96120728 |
138 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95617647 |
139 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.93165065 |
140 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.92307430 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.64238963 |
2 | MP0009785_altered_susceptibility_to | 3.08397040 |
3 | MP0000685_abnormal_immune_system | 2.92331622 |
4 | MP0003436_decreased_susceptibility_to | 2.90065667 |
5 | MP0002148_abnormal_hypersensitivity_rea | 2.72740684 |
6 | MP0003191_abnormal_cellular_cholesterol | 2.56742791 |
7 | MP0005671_abnormal_response_to | 2.54308565 |
8 | MP0002396_abnormal_hematopoietic_system | 2.47716815 |
9 | MP0005025_abnormal_response_to | 2.41120307 |
10 | MP0005000_abnormal_immune_tolerance | 2.40298628 |
11 | MP0001790_abnormal_immune_system | 2.28521018 |
12 | MP0005387_immune_system_phenotype | 2.28521018 |
13 | MP0003724_increased_susceptibility_to | 2.27764189 |
14 | MP0002419_abnormal_innate_immunity | 2.20364769 |
15 | MP0002452_abnormal_antigen_presenting | 2.16780953 |
16 | MP0001800_abnormal_humoral_immune | 2.10968656 |
17 | MP0002166_altered_tumor_susceptibility | 2.09504508 |
18 | MP0002723_abnormal_immune_serum | 2.05774362 |
19 | MP0008260_abnormal_autophagy | 2.04943461 |
20 | MP0001819_abnormal_immune_cell | 2.04173325 |
21 | MP0002420_abnormal_adaptive_immunity | 2.03801993 |
22 | MP0009333_abnormal_splenocyte_physiolog | 1.98054536 |
23 | MP0005397_hematopoietic_system_phenotyp | 1.94702391 |
24 | MP0001545_abnormal_hematopoietic_system | 1.94702391 |
25 | MP0003693_abnormal_embryo_hatching | 1.93053859 |
26 | MP0005464_abnormal_platelet_physiology | 1.91567896 |
27 | MP0004808_abnormal_hematopoietic_stem | 1.91282795 |
28 | MP0010352_gastrointestinal_tract_polyps | 1.88358999 |
29 | MP0001853_heart_inflammation | 1.88090966 |
30 | MP0002398_abnormal_bone_marrow | 1.85137924 |
31 | MP0005451_abnormal_body_composition | 1.84977028 |
32 | MP0003763_abnormal_thymus_physiology | 1.84018208 |
33 | MP0002006_tumorigenesis | 1.83958647 |
34 | MP0002405_respiratory_system_inflammati | 1.83398872 |
35 | MP0010155_abnormal_intestine_physiology | 1.81242804 |
36 | MP0003806_abnormal_nucleotide_metabolis | 1.76899406 |
37 | MP0000490_abnormal_crypts_of | 1.74927639 |
38 | MP0006054_spinal_hemorrhage | 1.73567463 |
39 | MP0000716_abnormal_immune_system | 1.69017860 |
40 | MP0003566_abnormal_cell_adhesion | 1.66993811 |
41 | MP0003303_peritoneal_inflammation | 1.65712606 |
42 | MP0000858_altered_metastatic_potential | 1.65118279 |
43 | MP0004947_skin_inflammation | 1.52906188 |
44 | MP0002877_abnormal_melanocyte_morpholog | 1.52694179 |
45 | MP0002722_abnormal_immune_system | 1.52597283 |
46 | MP0002429_abnormal_blood_cell | 1.52560089 |
47 | MP0001845_abnormal_inflammatory_respons | 1.52342799 |
48 | MP0001533_abnormal_skeleton_physiology | 1.51567709 |
49 | MP0000689_abnormal_spleen_morphology | 1.49920962 |
50 | MP0000465_gastrointestinal_hemorrhage | 1.44932331 |
51 | MP0006082_CNS_inflammation | 1.44193832 |
52 | MP0003300_gastrointestinal_ulcer | 1.36880015 |
53 | MP0003075_altered_response_to | 1.35429784 |
54 | MP0003448_altered_tumor_morphology | 1.35206385 |
55 | MP0001873_stomach_inflammation | 1.33820453 |
56 | MP0008007_abnormal_cellular_replicative | 1.30960077 |
57 | MP0000343_altered_response_to | 1.28708186 |
58 | MP0009278_abnormal_bone_marrow | 1.23683351 |
59 | MP0003866_abnormal_defecation | 1.23374995 |
60 | MP0009840_abnormal_foam_cell | 1.22544017 |
61 | MP0004957_abnormal_blastocyst_morpholog | 1.22462028 |
62 | MP0005023_abnormal_wound_healing | 1.20990262 |
63 | MP0003077_abnormal_cell_cycle | 1.19195866 |
64 | MP0008469_abnormal_protein_level | 1.16911584 |
65 | MP0010307_abnormal_tumor_latency | 1.16422063 |
66 | MP0005058_abnormal_lysosome_morphology | 1.13980779 |
67 | MP0003186_abnormal_redox_activity | 1.13372071 |
68 | MP0008438_abnormal_cutaneous_collagen | 1.13110383 |
69 | MP0010094_abnormal_chromosome_stability | 1.11556608 |
70 | MP0001348_abnormal_lacrimal_gland | 1.11322922 |
71 | MP0002019_abnormal_tumor_incidence | 1.10752339 |
72 | MP0000703_abnormal_thymus_morphology | 1.09995519 |
73 | MP0005164_abnormal_response_to | 1.08686727 |
74 | MP0004510_myositis | 1.06490079 |
75 | MP0003279_aneurysm | 1.06201065 |
76 | MP0005083_abnormal_biliary_tract | 1.06101073 |
77 | MP0005166_decreased_susceptibility_to | 1.04815140 |
78 | MP0008057_abnormal_DNA_replication | 1.04422220 |
79 | MP0004782_abnormal_surfactant_physiolog | 1.02337924 |
80 | MP0005174_abnormal_tail_pigmentation | 1.00616622 |
81 | MP0002163_abnormal_gland_morphology | 1.00048208 |
82 | MP0002933_joint_inflammation | 0.99857954 |
83 | MP0003183_abnormal_peptide_metabolism | 0.97464928 |
84 | MP0004883_abnormal_blood_vessel | 0.96892965 |
85 | MP0005165_increased_susceptibility_to | 0.96009142 |
86 | MP0001879_abnormal_lymphatic_vessel | 0.94499252 |
87 | MP0003656_abnormal_erythrocyte_physiolo | 0.94221296 |
88 | MP0002796_impaired_skin_barrier | 0.94037467 |
89 | MP0005076_abnormal_cell_differentiation | 0.93372797 |
90 | MP0003828_pulmonary_edema | 0.92930314 |
91 | MP0005310_abnormal_salivary_gland | 0.92278187 |
92 | MP0001849_ear_inflammation | 0.91561745 |
93 | MP0003111_abnormal_nucleus_morphology | 0.89563796 |
94 | MP0002132_abnormal_respiratory_system | 0.88979596 |
95 | MP0008004_abnormal_stomach_pH | 0.88667489 |
96 | MP0009764_decreased_sensitivity_to | 0.88465536 |
97 | MP0005501_abnormal_skin_physiology | 0.87841965 |
98 | MP0001958_emphysema | 0.86970831 |
99 | MP0003705_abnormal_hypodermis_morpholog | 0.86718144 |
100 | MP0005390_skeleton_phenotype | 0.84217352 |
101 | MP0000249_abnormal_blood_vessel | 0.82267237 |
102 | MP0003795_abnormal_bone_structure | 0.81549957 |
103 | MP0003172_abnormal_lysosome_physiology | 0.80655585 |
104 | MP0003091_abnormal_cell_migration | 0.80471303 |
105 | MP0010368_abnormal_lymphatic_system | 0.80144106 |
106 | MP0000313_abnormal_cell_death | 0.80057708 |
107 | MP0001663_abnormal_digestive_system | 0.78811651 |
108 | MP0002998_abnormal_bone_remodeling | 0.78130182 |
109 | MP0002060_abnormal_skin_morphology | 0.77817765 |
110 | MP0004381_abnormal_hair_follicle | 0.76863088 |
111 | MP0002138_abnormal_hepatobiliary_system | 0.76115554 |
112 | MP0001216_abnormal_epidermal_layer | 0.75962319 |
113 | MP0001915_intracranial_hemorrhage | 0.74227597 |
114 | MP0003045_fibrosis | 0.72170063 |
115 | MP0001851_eye_inflammation | 0.71747120 |
116 | MP0008874_decreased_physiological_sensi | 0.71665259 |
117 | MP0009931_abnormal_skin_appearance | 0.70921106 |
118 | MP0010234_abnormal_vibrissa_follicle | 0.70657028 |
119 | MP0008058_abnormal_DNA_repair | 0.69529868 |
120 | MP0000350_abnormal_cell_proliferation | 0.69457456 |
121 | MP0003943_abnormal_hepatobiliary_system | 0.69424929 |
122 | MP0005621_abnormal_cell_physiology | 0.68904562 |
123 | MP0009763_increased_sensitivity_to | 0.67354118 |
124 | MP0003453_abnormal_keratinocyte_physiol | 0.65659208 |
125 | MP0005275_abnormal_skin_tensile | 0.63374586 |
126 | MP0000477_abnormal_intestine_morphology | 0.62345105 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 4.64096623 |
2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.57966793 |
3 | Thrombocytosis (HP:0001894) | 4.33581410 |
4 | Eczematoid dermatitis (HP:0000976) | 4.20247363 |
5 | Myositis (HP:0100614) | 4.11980179 |
6 | Recurrent bacterial skin infections (HP:0005406) | 4.10744766 |
7 | Chronic otitis media (HP:0000389) | 3.97208655 |
8 | Interstitial pulmonary disease (HP:0006530) | 3.66461030 |
9 | Petechiae (HP:0000967) | 3.65213062 |
10 | Menorrhagia (HP:0000132) | 3.57235474 |
11 | Autoimmune thrombocytopenia (HP:0001973) | 3.44656047 |
12 | Abnormality of macrophages (HP:0004311) | 3.21698266 |
13 | Orchitis (HP:0100796) | 3.10921348 |
14 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.05752477 |
15 | IgM deficiency (HP:0002850) | 3.03781531 |
16 | Recurrent viral infections (HP:0004429) | 3.00649131 |
17 | Recurrent fungal infections (HP:0002841) | 2.99778302 |
18 | Abnormal number of erythroid precursors (HP:0012131) | 2.99420114 |
19 | Reticulocytopenia (HP:0001896) | 2.94658909 |
20 | Stomatitis (HP:0010280) | 2.91732745 |
21 | Cellulitis (HP:0100658) | 2.89245324 |
22 | Abnormality of T cell physiology (HP:0011840) | 2.86029055 |
23 | Abnormality of the nasal mucosa (HP:0000433) | 2.85038377 |
24 | Aplastic anemia (HP:0001915) | 2.83471125 |
25 | Vacuolated lymphocytes (HP:0001922) | 2.75064896 |
26 | Hepatosplenomegaly (HP:0001433) | 2.74158492 |
27 | Nasal polyposis (HP:0100582) | 2.72122275 |
28 | Mediastinal lymphadenopathy (HP:0100721) | 2.70666446 |
29 | Recurrent bronchitis (HP:0002837) | 2.65422479 |
30 | Vasculitis (HP:0002633) | 2.63397446 |
31 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.59126827 |
32 | Chronic obstructive pulmonary disease (HP:0006510) | 2.57697138 |
33 | Obstructive lung disease (HP:0006536) | 2.57697138 |
34 | Optic neuritis (HP:0100653) | 2.56677752 |
35 | Retrobulbar optic neuritis (HP:0100654) | 2.56677752 |
36 | Vertebral compression fractures (HP:0002953) | 2.56195863 |
37 | Recurrent skin infections (HP:0001581) | 2.54794971 |
38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.54303046 |
39 | Hypergammaglobulinemia (HP:0010702) | 2.53677889 |
40 | Pustule (HP:0200039) | 2.49910389 |
41 | Hypertensive crisis (HP:0100735) | 2.47131652 |
42 | Abnormality of T cells (HP:0002843) | 2.44150783 |
43 | Increased IgM level (HP:0003496) | 2.43392507 |
44 | Encephalitis (HP:0002383) | 2.41006591 |
45 | Basal ganglia calcification (HP:0002135) | 2.40912079 |
46 | Periodontitis (HP:0000704) | 2.39723974 |
47 | Prolonged bleeding time (HP:0003010) | 2.39701494 |
48 | Amyloidosis (HP:0011034) | 2.38763183 |
49 | Spontaneous hematomas (HP:0007420) | 2.38352924 |
50 | Increased serum ferritin (HP:0003281) | 2.37815753 |
51 | Distal lower limb muscle weakness (HP:0009053) | 2.37466107 |
52 | Osteolytic defects of the hand bones (HP:0009699) | 2.34193318 |
53 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.34193318 |
54 | Distal lower limb amyotrophy (HP:0008944) | 2.29642777 |
55 | Meningitis (HP:0001287) | 2.29632306 |
56 | Leukocytosis (HP:0001974) | 2.28435464 |
57 | Epistaxis (HP:0000421) | 2.26680463 |
58 | Poor head control (HP:0002421) | 2.20806912 |
59 | Dysostosis multiplex (HP:0000943) | 2.20464114 |
60 | Episodic fever (HP:0001954) | 2.19792519 |
61 | Skin ulcer (HP:0200042) | 2.18685425 |
62 | Polycythemia (HP:0001901) | 2.18481895 |
63 | Arterial thrombosis (HP:0004420) | 2.18122029 |
64 | Osteomyelitis (HP:0002754) | 2.14990058 |
65 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.14268573 |
66 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.14268573 |
67 | Abnormality of glycolipid metabolism (HP:0010969) | 2.14268573 |
68 | Abnormal platelet volume (HP:0011876) | 2.13757650 |
69 | Cervical subluxation (HP:0003308) | 2.12898241 |
70 | Pulmonary infiltrates (HP:0002113) | 2.12023845 |
71 | Granulocytopenia (HP:0001913) | 2.11849419 |
72 | Eosinophilia (HP:0001880) | 2.11056425 |
73 | Purpura (HP:0000979) | 2.10645874 |
74 | Abnormality of iron homeostasis (HP:0011031) | 2.10435365 |
75 | Abnormal platelet function (HP:0011869) | 2.09981838 |
76 | Impaired platelet aggregation (HP:0003540) | 2.09981838 |
77 | Reduced antithrombin III activity (HP:0001976) | 2.09908429 |
78 | Increased IgE level (HP:0003212) | 2.08574564 |
79 | Pallor (HP:0000980) | 2.08072624 |
80 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.07872954 |
81 | Hemoptysis (HP:0002105) | 2.07208573 |
82 | Gingivitis (HP:0000230) | 2.06506312 |
83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.06335162 |
84 | Bruising susceptibility (HP:0000978) | 2.05459590 |
85 | Amaurosis fugax (HP:0100576) | 2.04446909 |
86 | Broad face (HP:0000283) | 2.04213707 |
87 | Fatigue (HP:0012378) | 2.02257107 |
88 | Abnormality of T cell number (HP:0011839) | 1.98500268 |
89 | Premature rupture of membranes (HP:0001788) | 1.98279532 |
90 | Increased cerebral lipofuscin (HP:0011813) | 1.97570659 |
91 | Chest pain (HP:0100749) | 1.97215540 |
92 | Urticaria (HP:0001025) | 1.96186849 |
93 | Hypertriglyceridemia (HP:0002155) | 1.95293737 |
94 | Colitis (HP:0002583) | 1.95085094 |
95 | Autoimmune hemolytic anemia (HP:0001890) | 1.94725348 |
96 | 11 pairs of ribs (HP:0000878) | 1.93040401 |
97 | Lymphopenia (HP:0001888) | 1.92996428 |
98 | IgA deficiency (HP:0002720) | 1.92348624 |
99 | Loss of speech (HP:0002371) | 1.92066018 |
100 | Abnormality of the prostate (HP:0008775) | 1.91491990 |
101 | Hematochezia (HP:0002573) | 1.90902604 |
102 | Peritonitis (HP:0002586) | 1.90526055 |
103 | Beaking of vertebral bodies (HP:0004568) | 1.89877984 |
104 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.89533733 |
105 | Recurrent cutaneous fungal infections (HP:0011370) | 1.89533733 |
106 | Acute myeloid leukemia (HP:0004808) | 1.88876573 |
107 | Increased mean platelet volume (HP:0011877) | 1.88821649 |
108 | Glomerulopathy (HP:0100820) | 1.88527099 |
109 | Increased connective tissue (HP:0009025) | 1.88026981 |
110 | Polygenic inheritance (HP:0010982) | 1.87089131 |
111 | IgG deficiency (HP:0004315) | 1.86601786 |
112 | Gastrointestinal infarctions (HP:0005244) | 1.86211502 |
113 | Dilatation of the ascending aorta (HP:0005111) | 1.85188467 |
114 | Abnormality of eosinophils (HP:0001879) | 1.84658444 |
115 | Skin rash (HP:0000988) | 1.84161607 |
116 | Lymphoma (HP:0002665) | 1.82159013 |
117 | Gingival bleeding (HP:0000225) | 1.81916097 |
118 | Gastrointestinal dysmotility (HP:0002579) | 1.81836853 |
119 | Gastrointestinal stroma tumor (HP:0100723) | 1.81271948 |
120 | Type I transferrin isoform profile (HP:0003642) | 1.80583464 |
121 | Agammaglobulinemia (HP:0004432) | 1.79285149 |
122 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.78438117 |
123 | Increased density of long bones (HP:0006392) | 1.77133544 |
124 | Keratoconjunctivitis sicca (HP:0001097) | 1.75725632 |
125 | Gastrointestinal inflammation (HP:0004386) | 1.75218406 |
126 | Panhypogammaglobulinemia (HP:0003139) | 1.74893440 |
127 | Myocardial infarction (HP:0001658) | 1.74791487 |
128 | Protrusio acetabuli (HP:0003179) | 1.73412727 |
129 | Abnormality of the pericardium (HP:0001697) | 1.73364861 |
130 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.73047051 |
131 | Anorexia (HP:0002039) | 1.70782809 |
132 | Recurrent lower respiratory tract infections (HP:0002783) | 1.69864747 |
133 | Recurrent pneumonia (HP:0006532) | 1.69704162 |
134 | Inflammation of the large intestine (HP:0002037) | 1.69636756 |
135 | Cholecystitis (HP:0001082) | 1.69243074 |
136 | Abnormal gallbladder physiology (HP:0012438) | 1.69243074 |
137 | Keratoconjunctivitis (HP:0001096) | 1.69125749 |
138 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.68270299 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PIM2 | 3.00455465 |
2 | MAP4K1 | 2.91838180 |
3 | NME2 | 2.74868122 |
4 | MAP3K14 | 2.50860964 |
5 | PRPF4B | 2.45547358 |
6 | TBK1 | 2.42263704 |
7 | JAK3 | 2.31666953 |
8 | BLK | 2.15650746 |
9 | TYK2 | 2.09767479 |
10 | KIT | 2.05473191 |
11 | SMG1 | 2.02770381 |
12 | IRAK4 | 2.01313153 |
13 | ERN1 | 1.93359410 |
14 | TESK1 | 1.87919176 |
15 | RPS6KA4 | 1.85132148 |
16 | BTK | 1.85066444 |
17 | ZAP70 | 1.78703309 |
18 | LRRK2 | 1.77783581 |
19 | TEC | 1.77220521 |
20 | STK10 | 1.74721362 |
21 | KDR | 1.70709253 |
22 | TGFBR1 | 1.67733680 |
23 | ACVR1B | 1.65531385 |
24 | IKBKB | 1.62718800 |
25 | MAP2K3 | 1.61474310 |
26 | FES | 1.59199726 |
27 | FLT3 | 1.57433546 |
28 | TAOK2 | 1.53931306 |
29 | IKBKE | 1.53242115 |
30 | TXK | 1.51070172 |
31 | WEE1 | 1.46031698 |
32 | SCYL2 | 1.45070234 |
33 | TESK2 | 1.39227048 |
34 | RPS6KB2 | 1.38514652 |
35 | EEF2K | 1.37325563 |
36 | TRIB3 | 1.35115793 |
37 | MST1R | 1.26728948 |
38 | SIK1 | 1.26671452 |
39 | PIM1 | 1.23231767 |
40 | PKN2 | 1.22808922 |
41 | MAP3K1 | 1.20726285 |
42 | PAK4 | 1.19956873 |
43 | MST4 | 1.19896427 |
44 | NEK9 | 1.19325732 |
45 | IRAK3 | 1.12840639 |
46 | TIE1 | 1.12487049 |
47 | TAOK1 | 1.12425554 |
48 | BRSK2 | 1.12295854 |
49 | EIF2AK3 | 1.12142815 |
50 | TNK2 | 1.11918455 |
51 | EIF2AK1 | 1.11358640 |
52 | CSF1R | 1.10625963 |
53 | MAP3K13 | 1.09768614 |
54 | MAP3K11 | 1.09761953 |
55 | ARAF | 1.09150373 |
56 | SYK | 1.09026704 |
57 | TGFBR2 | 1.07167314 |
58 | STK16 | 1.06999537 |
59 | BUB1 | 1.03033062 |
60 | EPHA2 | 1.00764560 |
61 | CHUK | 0.98908520 |
62 | TRPM7 | 0.96302239 |
63 | MAP3K3 | 0.95204590 |
64 | JAK1 | 0.94623590 |
65 | MATK | 0.91614245 |
66 | EPHB1 | 0.90391882 |
67 | KSR2 | 0.88599499 |
68 | MAPKAPK3 | 0.88029670 |
69 | TTN | 0.87586394 |
70 | LMTK2 | 0.87502681 |
71 | FGR | 0.85701513 |
72 | MAP3K8 | 0.83800641 |
73 | ILK | 0.83385001 |
74 | BMPR2 | 0.82598553 |
75 | CDC7 | 0.82181978 |
76 | LCK | 0.81809936 |
77 | JAK2 | 0.78680533 |
78 | ITK | 0.78000886 |
79 | HCK | 0.77887156 |
80 | PRKD2 | 0.77830703 |
81 | NEK2 | 0.77801021 |
82 | TAOK3 | 0.77457764 |
83 | PRKG2 | 0.76977632 |
84 | PTK2B | 0.75953257 |
85 | MAPKAPK2 | 0.75485023 |
86 | NLK | 0.73487515 |
87 | VRK1 | 0.71887537 |
88 | PDPK1 | 0.71411035 |
89 | LYN | 0.71294449 |
90 | MAP3K6 | 0.69626780 |
91 | STK4 | 0.69353137 |
92 | LIMK1 | 0.68803626 |
93 | CSK | 0.67694523 |
94 | CDK6 | 0.67074237 |
95 | CDK7 | 0.66979529 |
96 | MAP3K12 | 0.65798386 |
97 | HIPK2 | 0.65427530 |
98 | IRAK1 | 0.65112997 |
99 | PTK6 | 0.64925326 |
100 | PASK | 0.64226239 |
101 | IRAK2 | 0.61544271 |
102 | CDK4 | 0.61419945 |
103 | ABL2 | 0.60612264 |
104 | EIF2AK2 | 0.60036362 |
105 | MAP3K2 | 0.59923564 |
106 | MYLK | 0.59070431 |
107 | MOS | 0.58656774 |
108 | RAF1 | 0.56931982 |
109 | VRK2 | 0.55809795 |
110 | CDC42BPA | 0.55384121 |
111 | PDK1 | 0.54478991 |
112 | PTK2 | 0.53818990 |
113 | AURKB | 0.52522610 |
114 | TSSK6 | 0.51947378 |
115 | YES1 | 0.49998936 |
116 | RIPK1 | 0.49842650 |
117 | RPS6KA6 | 0.49215574 |
118 | MAPK11 | 0.48921908 |
119 | DAPK1 | 0.47586279 |
120 | ATR | 0.46967380 |
121 | STK24 | 0.46578731 |
122 | BMX | 0.45991124 |
123 | PIK3CG | 0.45609800 |
124 | RIPK4 | 0.44774116 |
125 | SIK3 | 0.44761147 |
126 | FGFR4 | 0.44453018 |
127 | MAP2K2 | 0.43880620 |
128 | PAK1 | 0.43465964 |
129 | GRK6 | 0.42653323 |
130 | MARK2 | 0.41756231 |
131 | CLK1 | 0.41374502 |
132 | STK38 | 0.39870480 |
133 | PRKCD | 0.39598705 |
134 | MAPK12 | 0.39278912 |
135 | MARK3 | 0.38195778 |
136 | MAP3K10 | 0.37994457 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 2.82953211 |
2 | Ribosome_Homo sapiens_hsa03010 | 2.55061063 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 2.39555869 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.38864481 |
5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.35545325 |
6 | Proteasome_Homo sapiens_hsa03050 | 2.14827062 |
7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.08949391 |
8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.95021920 |
9 | Legionellosis_Homo sapiens_hsa05134 | 1.92868311 |
10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.89721473 |
11 | Measles_Homo sapiens_hsa05162 | 1.87626164 |
12 | Mismatch repair_Homo sapiens_hsa03430 | 1.84376246 |
13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82834022 |
14 | Base excision repair_Homo sapiens_hsa03410 | 1.75256362 |
15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.75248309 |
16 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.73043873 |
17 | Shigellosis_Homo sapiens_hsa05131 | 1.69427859 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.66054625 |
19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.63478612 |
20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.63197605 |
21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.62892829 |
22 | Pertussis_Homo sapiens_hsa05133 | 1.57767809 |
23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.52379140 |
24 | Apoptosis_Homo sapiens_hsa04210 | 1.47056847 |
25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44836571 |
26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43447909 |
27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.43287594 |
28 | Malaria_Homo sapiens_hsa05144 | 1.43016673 |
29 | Influenza A_Homo sapiens_hsa05164 | 1.41172207 |
30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39221085 |
31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33957578 |
32 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.31953536 |
33 | Homologous recombination_Homo sapiens_hsa03440 | 1.30165911 |
34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.29728237 |
35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28411217 |
36 | Salmonella infection_Homo sapiens_hsa05132 | 1.25341638 |
37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.25068469 |
38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.24122104 |
39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.22848754 |
40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20188908 |
41 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.19979129 |
42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19528753 |
43 | Asthma_Homo sapiens_hsa05310 | 1.15974645 |
44 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.15828586 |
45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14503975 |
46 | Tuberculosis_Homo sapiens_hsa05152 | 1.14059181 |
47 | Hepatitis B_Homo sapiens_hsa05161 | 1.13919108 |
48 | Endocytosis_Homo sapiens_hsa04144 | 1.12119027 |
49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11938891 |
50 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.09608752 |
51 | Cell cycle_Homo sapiens_hsa04110 | 1.06013730 |
52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05663508 |
53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05538396 |
54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04249650 |
55 | Spliceosome_Homo sapiens_hsa03040 | 1.03964744 |
56 | Bladder cancer_Homo sapiens_hsa05219 | 1.01909109 |
57 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.01865110 |
58 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.01807855 |
59 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.99348013 |
60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98030703 |
61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90821699 |
62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90509399 |
63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88455160 |
64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88352659 |
65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87333748 |
66 | Platelet activation_Homo sapiens_hsa04611 | 0.87310625 |
67 | Lysosome_Homo sapiens_hsa04142 | 0.85595679 |
68 | RNA polymerase_Homo sapiens_hsa03020 | 0.85216077 |
69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85104003 |
70 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84827066 |
71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83560309 |
72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83381078 |
73 | Thyroid cancer_Homo sapiens_hsa05216 | 0.81596047 |
74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81418466 |
75 | Protein export_Homo sapiens_hsa03060 | 0.81241283 |
76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81030374 |
77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80179911 |
78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79650695 |
79 | RNA transport_Homo sapiens_hsa03013 | 0.78566822 |
80 | Phagosome_Homo sapiens_hsa04145 | 0.77783471 |
81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74373327 |
82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73575040 |
83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72787468 |
84 | Hepatitis C_Homo sapiens_hsa05160 | 0.72665836 |
85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71758237 |
86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70966552 |
87 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69390421 |
88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66493952 |
89 | Amoebiasis_Homo sapiens_hsa05146 | 0.66051748 |
90 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.66023930 |
91 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65818111 |
92 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65099307 |
93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.64515389 |
94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63324648 |
95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62780494 |
96 | RNA degradation_Homo sapiens_hsa03018 | 0.57397066 |
97 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.56840047 |
98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56677792 |
99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54976313 |
100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52233875 |
101 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51620949 |
102 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50559231 |
103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50496729 |
104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50002681 |
105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48348685 |
106 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.48334712 |
107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47652751 |
108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46087026 |
109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45813142 |
110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44564453 |
111 | Focal adhesion_Homo sapiens_hsa04510 | 0.44544455 |
112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.43673479 |
113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42007420 |
114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41559414 |
115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40324985 |
116 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.39468743 |
117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38565739 |
118 | Adherens junction_Homo sapiens_hsa04520 | 0.38481324 |
119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38189533 |
120 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37379943 |
121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35308127 |
122 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33997350 |
123 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.33779223 |
124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32660058 |